Lanean...
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local failure suggests the efficacy of RT needs to be impr...
Gorde:
| Argitaratua izan da: | Neurooncol Pract |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274183/ https://ncbi.nlm.nih.gov/pubmed/32537176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz057 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|